Today's Analyst Stock Ratings | Upgrades, Downgrades

							Get Alert
Aug 3, 2026	THCTenet Healthcare	$264.54	6.22%	Stephen BaxterWells Fargo 69%	231 281	Previous Overweight Current Overweight	Get Alert
Jul 28, 2026	THCTenet Healthcare	$264.54	9.62%	David MacdonaldTruist Securities 70%	270 290	Previous Buy Current Buy	Get Alert
Jul 28, 2026	THCTenet Healthcare	$264.54	5.84%	Michael HaBaird 41%	210 280	Previous Neutral Current Neutral	Get Alert
Jul 28, 2026	THCTenet Healthcare	$264.54	6.98%	Jason CassorlaGuggenheim 63%	242 283	Previous Buy Current Buy	Get Alert
Jul 27, 2026	THCTenet Healthcare	$264.54	16.43%	A.J. RiceUBS 70%	288 308	Previous Buy Current Buy	Get Alert
Jul 27, 2026	THCTenet Healthcare	$264.54	-0.58%	Ryan LangstonTD Cowen 53%	233 263	Previous Buy Current Buy	Get Alert
Jul 27, 2026	THCTenet Healthcare	$264.54	3.58%	Craig HettenbachMorgan Stanley 60%	254 274	Previous Overweight Current Overweight	Get Alert
Jul 27, 2026	THCTenet Healthcare	$264.54	6.98%	Ben HendrixRBC Capital 65%	236 283	Previous Outperform Current Outperform	Get Alert
Jul 24, 2026	THCTenet Healthcare	$264.54	2.44%	Andrew MokBarclays 59%	240 271	Previous Overweight Current Overweight	Get Alert
Jul 20, 2026	THCTenet Healthcare	$264.54	-8.52%	Jason CassorlaGuggenheim 63%	242 252	Previous Buy Current Buy	Get Alert
Jul 13, 2026	THCTenet Healthcare	$264.54	-12.68%	Stephen BaxterWells Fargo 69%	213 231	Previous Overweight Current Overweight	Get Alert
Jul 9, 2026	THCTenet Healthcare	$264.54	-9.28%	Andrew MokBarclays 59%	238 240	Previous Overweight Current Overweight	Get Alert
Jun 22, 2026	THCTenet Healthcare	$264.54	-11.92%	Ryan LangstonTD Cowen 53%	233 242	Previous Buy Current Buy	Get Alert
May 5, 2026	THCTenet Healthcare	$264.54	-10.03%	Andrew MokBarclays 59%	238 257	Previous Overweight Current Overweight	Get Alert
May 5, 2026	THCTenet Healthcare	$264.54	-20.62%	Michael HaBaird 41%	210 245	Previous Neutral Current Neutral	Get Alert
May 4, 2026	THCTenet Healthcare	$264.54	-1.72%	Raj Kumar Stephens & Co. 61%	260 275	Previous Overweight Current Overweight	Get Alert
May 1, 2026	THCTenet Healthcare	$264.54	-10.79%	Ben HendrixRBC Capital 65%	236 277	Previous Outperform Current Outperform	Get Alert
May 1, 2026	THCTenet Healthcare	$264.54	-4.74%	Jason CassorlaGuggenheim 63%	252 283	Previous Buy Current Buy	Get Alert
May 1, 2026	THCTenet Healthcare	$264.54	-19.48%	Stephen BaxterWells Fargo 69%	213 265	Previous Overweight Current Overweight	Get Alert
May 1, 2026	THCTenet Healthcare	$264.54	-14.95%	Matthew GillmorKeybanc 66%	225 250	Previous Overweight Current Overweight	Get Alert
Mar 12, 2026	THCTenet Healthcare	$264.54	6.98%	Jason CassorlaGuggenheim 63%	271 283	Previous Buy Current Buy	Get Alert
Mar 12, 2026	THCTenet Healthcare	$264.54	0.17%	Ann HynesMizuho 73%	235 265	Previous Outperform Current Outperform	Get Alert
Feb 20, 2026	THCTenet Healthcare	$264.54	-0.2%	Whit MayoLeerink Partners 64%	255 264	Previous Outperform Current Outperform	Get Alert
Feb 17, 2026	THCTenet Healthcare	$264.54	2.06%	David MacdonaldTruist Securities 70%	240 270	Previous Buy Current Buy	Get Alert
Feb 13, 2026	THCTenet Healthcare	$264.54	-2.85%	Andrew MokBarclays 59%	240 257	Previous Overweight Current Overweight	Get Alert
Feb 13, 2026	THCTenet Healthcare	$264.54	2.44%	Jason CassorlaGuggenheim 63%	257 271	Previous Buy Current Buy	Get Alert
Feb 12, 2026	THCTenet Healthcare	$264.54	0.17%	Brian TanquilutJefferies 68%	250 265	Previous Buy Current Buy	Get Alert
Feb 12, 2026	THCTenet Healthcare	$264.54	4.71%	Ben HendrixRBC Capital 65%	253 277	Previous Outperform Current Outperform	Get Alert
Feb 12, 2026	THCTenet Healthcare	$264.54	8.87%	A.J. RiceUBS 70%	260 288	Previous Buy Current Buy	Get Alert
Feb 12, 2026	THCTenet Healthcare	$264.54	-5.5%	Matthew GillmorKeybanc 66%	225 250	Previous Overweight Current Overweight	Get Alert
Feb 3, 2026	THCTenet Healthcare	$264.54	-4.36%	Ben HendrixRBC Capital 65%	252 253	Previous Outperform Current Outperform	Get Alert
Jan 7, 2026	THCTenet Healthcare	$264.54	-13.43%	Stephen BaxterWells Fargo 69%	229 252	Previous Overweight Current Overweight	Get Alert
Jan 7, 2026	THCTenet Healthcare	$264.54	-13.06%	Ryan LangstonTD Cowen 53%	230 233	Previous Buy Current Buy	Get Alert
Dec 2, 2025	THCTenet Healthcare	$264.54	-2.85%	Jason CassorlaGuggenheim 63%	238 257	Previous Buy Current Buy	Get Alert
Nov 21, 2025	THCTenet Healthcare	$264.54	-9.28%	Andrew MokBarclays 59%	229 240	Previous Overweight Current Overweight	Get Alert
Nov 13, 2025	THCTenet Healthcare	$264.54	-13.06%	Benjamin RossiJP Morgan 60%	200 230	Previous Overweight Current Overweight	Get Alert
Nov 13, 2025	THCTenet Healthcare	$264.54	-4.74%	Stephen BaxterWells Fargo 69%	238 252	Previous Overweight Current Overweight	Get Alert
Nov 3, 2025	THCTenet Healthcare	$264.54	-9.28%	David MacdonaldTruist Securities 70%	225 240	Previous Buy Current Buy	Get Alert
Oct 30, 2025	THCTenet Healthcare	$264.54	-4.74%	Ben HendrixRBC Capital 65%	230 252	Previous Outperform Current Outperform	Get Alert
Oct 29, 2025	THCTenet Healthcare	$264.54	-1.72%	A.J. RiceUBS 70%	238 260	Previous Buy Current Buy	Get Alert
Oct 29, 2025	THCTenet Healthcare	$264.54	-7.39%	Sarah JamesCantor Fitzgerald 47%	190 245	Previous Overweight Current Overweight	Get Alert
Oct 29, 2025	THCTenet Healthcare	$264.54	-10.03%	Jason CassorlaGuggenheim 63%	221 238	Previous Buy Current Buy	Get Alert
Oct 17, 2025	THCTenet Healthcare	$264.54	-14.95%	Ann HynesMizuho 73%	194 225	Previous Outperform Current Outperform	Get Alert
Oct 14, 2025	THCTenet Healthcare	$264.54	-15.32%	Scott Fidel Goldman Sachs 49%	224	Previous Current Buy	Get Alert
Oct 8, 2025	THCTenet Healthcare	$264.54	-14.95%	Scott SchoenhausKeybanc 43%	205 225	Previous Overweight Current Overweight	Get Alert
Oct 7, 2025	THCTenet Healthcare	$264.54	-10.03%	Stephen BaxterWells Fargo 69%	200 238	Previous Overweight Current Overweight	Get Alert
Oct 7, 2025	THCTenet Healthcare	$264.54	-28.18%	Sarah JamesCantor Fitzgerald 47%	190 190	Previous Overweight Current Overweight	Get Alert
Sep 18, 2025	THCTenet Healthcare	$264.54	-13.43%	Andrew MokBarclays 59%	208 229	Previous Overweight Current Overweight	Get Alert
Sep 10, 2025	THCTenet Healthcare	$264.54	-14.95%	Kevin FischbeckB of A Securities 68%	205 225	Previous Buy Current Buy	Get Alert
Aug 26, 2025	THCTenet Healthcare	$264.54	-28.18%	Sarah JamesCantor Fitzgerald 47%	190 190	Previous Overweight Current Overweight	Get Alert
Aug 14, 2025	THCTenet Healthcare	$264.54	-24.4%	Stephen BaxterWells Fargo 69%	195 200	Previous Overweight Current Overweight	Get Alert
Aug 4, 2025	THCTenet Healthcare	$264.54	-24.4%	Benjamin RossiJP Morgan 60%	190 200	Previous Overweight Current Overweight	Get Alert
Jul 28, 2025	THCTenet Healthcare	$264.54	—	Justin LakeWolfe Research 43%	—	Previous Outperform Current Peer Perform	Get Alert
Jul 25, 2025	THCTenet Healthcare	$264.54	-36.87%	Michael HaBaird 41%	167 195	Previous Neutral Current Neutral	Get Alert
Jul 24, 2025	THCTenet Healthcare	$264.54	-21.37%	Andrew MokBarclays 59%	208 215	Previous Overweight Current Overweight	Get Alert
Jul 23, 2025	THCTenet Healthcare	$264.54	-22.51%	Kevin FischbeckB of A Securities 68%	195 205	Previous Buy Current Buy	Get Alert
Jul 23, 2025	THCTenet Healthcare	$264.54	-10.03%	A.J. RiceUBS 70%	230 238	Previous Buy Current Buy	Get Alert
Jul 23, 2025	THCTenet Healthcare	$264.54	-24.4%	John RansomRaymond James 76%	185 200	Previous Outperform Current Outperform	Get Alert
Jul 23, 2025	THCTenet Healthcare	$264.54	-28.93%	Jason CassorlaGuggenheim 63%	180 188	Previous Buy Current Buy	Get Alert
Jul 16, 2025	THCTenet Healthcare	$264.54	-22.51%	David MacdonaldTruist Securities 70%	190 205	Previous Buy Current Buy	Get Alert
Jul 11, 2025	THCTenet Healthcare	$264.54	-26.67%	Ann HynesMizuho 73%	184 194	Previous Outperform Current Outperform	Get Alert
Jun 9, 2025	THCTenet Healthcare	$264.54	-20.62%	Craig HettenbachMorgan Stanley 60%	175 210	Previous Overweight Current Overweight	Get Alert
Jun 2, 2025	THCTenet Healthcare	$264.54	-18.73%	Andrew MokBarclays 59%	171 215	Previous Overweight Current Overweight	Get Alert
May 29, 2025	THCTenet Healthcare	$264.54	-26.29%	Stephen BaxterWells Fargo 69%	150 195	Previous Equal-Weight Current Overweight	Get Alert
May 14, 2025	THCTenet Healthcare	$264.54	-31.96%	Kevin FischbeckB of A Securities 68%	165 180	Previous Buy Current Buy	Get Alert
May 12, 2025	THCTenet Healthcare	$264.54	-28.18%	David MacdonaldTruist Securities 70%	175 190	Previous Buy Current Buy	Get Alert
May 5, 2025	THCTenet Healthcare	$264.54	-41.79%	Jamie PerseGoldman Sachs 62%	134 154	Previous Neutral Current Neutral	Get Alert
May 5, 2025	THCTenet Healthcare	$264.54	-33.85%	Craig HettenbachMorgan Stanley 60%	165 175	Previous Overweight Current Overweight	Get Alert
Apr 30, 2025	THCTenet Healthcare	$264.54	-35.36%	Andrew MokBarclays 59%	161 171	Previous Overweight Current Overweight	Get Alert
Apr 30, 2025	THCTenet Healthcare	$264.54	-28.56%	Ben HendrixRBC Capital 65%	183 189	Previous Outperform Current Outperform	Get Alert
Apr 30, 2025	THCTenet Healthcare	$264.54	-13.06%	A.J. RiceUBS 70%	217 230	Previous Buy Current Buy	Get Alert
Apr 15, 2025	THCTenet Healthcare	$264.54	-48.21%	Michael HaBaird 41%	137 153	Previous Outperform Current Neutral	Get Alert
Apr 9, 2025	THCTenet Healthcare	$264.54	-37.63%	Jason CassorlaGuggenheim 63%	165	Previous Initiates Current Buy	Get Alert
Mar 26, 2025	THCTenet Healthcare	$264.54	-37.63%	Craig HettenbachMorgan Stanley 60%	165	Previous Initiates Current Overweight	Get Alert
Feb 13, 2025	THCTenet Healthcare	$264.54	-33.09%	Sarah JamesCantor Fitzgerald 47%	177 177	Previous Overweight Current Overweight	Get Alert
Feb 13, 2025	THCTenet Healthcare	$264.54	-39.14%	Andrew MokBarclays 59%	161 190	Previous Overweight Current Overweight	Get Alert
Jan 7, 2025	THCTenet Healthcare	$264.54	-30.07%	Tim RezvanKeybanc 58%	185 200	Previous Overweight Current Overweight	Get Alert
Jan 6, 2025	THCTenet Healthcare	$264.54	-33.85%	David MacdonaldTruist Securities 70%	175 190	Previous Buy Current Buy	Get Alert
Dec 17, 2024	THCTenet Healthcare	$264.54	-33.85%	Benjamin RossiJP Morgan 60%	175	Previous Current Overweight	Get Alert
Dec 16, 2024	THCTenet Healthcare	$264.54	-47.08%	Jamie PerseGoldman Sachs 62%	140 196	Previous Buy Current Neutral	Get Alert
Nov 25, 2024	THCTenet Healthcare	$264.54	-43.3%	Stephen BaxterWells Fargo 69%	150 205	Previous Overweight Current Equal-Weight	Get Alert
Nov 22, 2024	THCTenet Healthcare	$264.54	-26.29%	John RansomRaymond James 76%	195 195	Previous Strong Buy Current Outperform	Get Alert
Nov 8, 2024	THCTenet Healthcare	$264.54	-28.18%	Andrew MokBarclays 59%	171 190	Previous Overweight Current Overweight	Get Alert
Nov 6, 2024	THCTenet Healthcare	$264.54	-22.51%	Stephen BaxterWells Fargo 69%	195 205	Previous Overweight Current Overweight	Get Alert
Oct 30, 2024	THCTenet Healthcare	$264.54	-33.09%	Sarah JamesCantor Fitzgerald 47%	168 177	Previous Overweight Current Overweight	Get Alert
Oct 30, 2024	THCTenet Healthcare	$264.54	-25.91%	Jamie PerseGoldman Sachs 62%	173 196	Previous Buy Current Buy	Get Alert
Oct 30, 2024	THCTenet Healthcare	$264.54	-30.82%	Ben HendrixRBC Capital 65%	174 183	Previous Outperform Current Outperform	Get Alert
Oct 30, 2024	THCTenet Healthcare	$264.54	-28.18%	David MacdonaldTruist Securities 70%	180 190	Previous Buy Current Buy	Get Alert
Oct 30, 2024	THCTenet Healthcare	$264.54	-17.97%	A.J. RiceUBS 70%	197 217	Previous Buy Current Buy	Get Alert
Oct 22, 2024	THCTenet Healthcare	$264.54	-26.29%	Stephen BaxterWells Fargo 69%	175 195	Previous Overweight Current Overweight	Get Alert
Oct 14, 2024	THCTenet Healthcare	$264.54	-31.96%	David MacdonaldTruist Securities 70%	170 180	Previous Buy Current Buy	Get Alert
Oct 11, 2024	THCTenet Healthcare	$264.54	-24.4%	Matthew GillmorKeybanc 66%	200	Previous Initiates Current Overweight	Get Alert
Oct 4, 2024	THCTenet Healthcare	$264.54	-36.49%	Sarah JamesCantor Fitzgerald 47%	168 168	Previous Overweight Current Overweight	Get Alert
Oct 1, 2024	THCTenet Healthcare	$264.54	-36.49%	Sarah JamesCantor Fitzgerald 47%	168 168	Previous Overweight Current Overweight	Get Alert
Aug 20, 2024	THCTenet Healthcare	$264.54	-36.49%	Sarah JamesCantor Fitzgerald 47%	168 168	Previous Overweight Current Overweight	Get Alert
Aug 19, 2024	THCTenet Healthcare	$264.54	-36.49%	Sarah JamesCantor Fitzgerald 47%	168 168	Previous Overweight Current Overweight	Get Alert
Aug 14, 2024	THCTenet Healthcare	$264.54	-25.53%	A.J. RiceUBS 70%	180 197	Previous Buy Current Buy	Get Alert
Jul 30, 2024	THCTenet Healthcare	$264.54	-34.6%	Jamie PerseGoldman Sachs 62%	156 173	Previous Buy Current Buy	Get Alert
Jul 30, 2024	THCTenet Healthcare	$264.54	-33.85%	Stephen BaxterWells Fargo 69%	145 175	Previous Overweight Current Overweight	Get Alert
Jul 29, 2024	THCTenet Healthcare	$264.54	-35.36%	Andrew MokBarclays 59%	156 171	Previous Overweight Current Overweight	Get Alert

Recent Analyst Stock Rating News

PRO

Bernstein Initiates Coverage On FedEx Freight Hldg Co with Market Perform Rating, Announces Price Target of $133

Bernstein analyst David Vernon initiates coverage on FedEx Freight Hldg Co (NYSE:FDXF) with a Market Perform rating and announces Price Target of $133.

PRO

JP Morgan Maintains Underweight on Sunbelt Rentals Holdings, Raises Price Target to $79

JP Morgan analyst Tami Zakaria maintains Sunbelt Rentals Holdings (NYSE:SUNB) with a Underweight and raises the price target from $71 to $79.

PRO

Bernstein Initiates Coverage On Old Dominion Freight Line with Market Perform Rating, Announces Price Target of $200

Bernstein analyst David Vernon initiates coverage on Old Dominion Freight Line (NASDAQ:ODFL) with a Market Perform rating and announces Price Target of $200.

PRO

JP Morgan Maintains Overweight on Concentra Group Holdings, Raises Price Target to $43

JP Morgan analyst Benjamin Rossi maintains Concentra Group Holdings (NYSE:CON) with a Overweight and raises the price target from $34 to $43.

Signet Analysts Increase Their Forecasts After Better-Than-Expected Q2 Earnings

Signet beat Q2 EPS estimates and raised FY27 adjusted EPS guidance, but missed sales expectations; shares fell 5.4%.

PRO

Bernstein Initiates Coverage On XPO with Outperform Rating, Announces Price Target of $244

Bernstein analyst David Vernon initiates coverage on XPO (NYSE:XPO) with a Outperform rating and announces Price Target of $244.

PRO

JP Morgan Maintains Overweight on BBB Foods, Raises Price Target to $67

JP Morgan analyst Joseph Giordano maintains BBB Foods (NYSE:TBBB) with a Overweight and raises the price target from $48 to $67.

PRO

Bernstein Initiates Coverage On Saia with Outperform Rating, Announces Price Target of $439

Bernstein analyst David Vernon initiates coverage on Saia (NASDAQ:SAIA) with a Outperform rating and announces Price Target of $439.

PRO

JP Morgan Maintains Overweight on AeroVironment, Raises Price Target to $210

JP Morgan analyst Seth Seifman maintains AeroVironment (NASDAQ:AVAV) with a Overweight and raises the price target from $200 to $210.

PRO

Bernstein Initiates Coverage On Knight-Swift with Outperform Rating, Announces Price Target of $91

Bernstein analyst David Vernon initiates coverage on Knight-Swift (NYSE:KNX) with a Outperform rating and announces Price Target of $91.

The Best Trading Research Platform

For Retail Investors and Professional Trades Alike.

Get Started for Free

What Are Analyst Stock Ratings?

Analyst ratings measure the expected performance of a stock during a given time period. Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders.

Analysts arrive at stock ratings after they research companies’ public financial statements, communicate with executives and customers and interact with companies in other ways.

Most analysts issue ratings 4 times a year, usually at 3-month intervals.

How to Use Analyst Ratings

As an investor or trader, you want to be able to use analyst ratings effectively. Here are steps you can take to understand how to synthesize all the information analysts report about a particular company and how to apply it to your own trades.

Step 1: Check Ratings History

In the short term, look to see whether analysts suggest an initiation, upgrade or downgrade for a particular stock. Understand how the rating changed compared to the previous rating and whether a price target gets announced or changed.

Sometimes the rating stays the same and only the price target changes, which could cause the stock to move in either direction, depending on the significance of the change between the 2 price targets.

Step 2: Check for Other News

In the short term, check to see how the stock reacts to positive or negative news. This will be an indication of the company’s outlook because analyst ratings usually come out after the company announces news (it’ll typically be earnings news).

Step 3: Look at the Sector for News

Check to see if other stocks in the sector also received similar ratings. This could indicate micro news, which refers to when the whole sector or specific company trades in a specific way due to news outside of one company.

Step 4: Look at the Note

If available, look over the analyst note itself. The beginning of the note has the main information of the rating and price target. Investors should also take a look at the summary of the note, which you can find in the first couple pages and give you a concrete overview of the company. This can help you get an understanding of how analysts arrived at their thesis on the stock.

An example of an analyst note. Source: Needham

Step 5: Make a Decision

After reviewing the analyst ratings (and whether the analyst proposes a change or initiation) and find the reason for that note. Make a decision based on the analyst thesis on the company. This should give you guidance on how to make your thesis. Analyst ratings are a good indication of what professionals believe the company or sector will do, helping you get a better understanding of the companies you’re interested in.

Analyst Rating Accuracy

Analyst ratings are not set in stone and nobody knows indefinitely what a stock will do. Therefore, analyst ratings should be taken as an educated guess made by professionals who carefully study the specific company and sector in question. It's not a surprise that the accuracy of each rating can vary by each individual analyst and specific ratings on companies.

In other words, there’s no hard number or percentage on how accurate analyst ratings are because they are like educated guesses on what they think the stock will do based on their research, within that particular sector. In addition, each firm has so many analysts and so many different companies to review that you can compare ratings to glean what you believe is the truth.

Where Analyst Ratings Come From

Analyst ratings come from stock analysts. Analysts “go deep” on companies within a particular industry or sector. Some analysts employ a top-down approach (they start with an industry or sector and look for excellent companies within that industry or sector) and other stock analysts choose a bottom-up approach, which means they start with the company first and connect the dots within that company’s sector or industry. Analysts evaluate:

Financial statements
Economic fundamentals
Suppliers, customers and competitors
Management quality
Business model
Revenue
Expenses
Assets
Liabilities

While these evaluations are done using facts and figures that any investor can access, they come down to a conclusion the analyst must draw. While this isn’t an unqualified opinion, analysts will disagree because their interpretations of the data could vary.

Types of Stock Ratings

Stock ratings can range from simple “buy” and “sell” ratings to “equal weight” and “outperform” ratings. Here’s a quick overview of how analysts rate stocks.

Buy Rating

A “buy” rating indicates that an analyst is optimistic about a stock’s short-term or mid-term growth and recommends that traders purchase the stock. An analyst may even go so far as to indicate that a stock is a “strong buy.” At the same time, you may choose to swing trade the asset for a profit and come back later to start the process all over again.

Sell Rating

A “sell” rating means that an analyst believes the stock will trend downward in a particular time frame. Analysts might even refer to a security as a “strong sell.” Remember, though, you may want to swing trade and come back to this asset in the future even though you just chose to sell, just as you would under a “buy” rating.

Hold

A “hold” rating suggests that investors should not buy more of or sell the specified stock because they believe the stock should perform in a way that’s consistent with the market or will perform similarly to comparable companies within that particular sector. This is akin to the value investing approach that Warren Buffett uses, looking to gain long-term value from a single stock rather than flipping it because of a bad week. As many have said, it’s not a loss until you sell.

Underperform

An “underperform” rating means an analyst indicates that a stock is expected to perform below the market or sector average. And yes, while the underperform rating may not bode well for an asset in the next few weeks, it may not stay that way. Continue to carefully monitor your portfolio to ensure that an underperforming asset hasn’t turned itself around. As companies are faced with the Herculean task of pleasing shareholders, they will push to fix their underperforming stocks, meaning that a stock you wrote off could rise again.

Outperform

An “outperform” rating means that an analyst expects a stock to outperform the market or sector average. While the stock may look to outperform the market or a sector’s average, that doesn’t mean it will continue to soar forever. You must look at an outperform rating as what that asset will do in recent times, but it may not maintain that trajectory.

Equal-Weight

An equal weight rating means that an analyst believes that an individual stock's performance will tie to the average of all the stocks that an analyst covers in that particular sector. This type of rating helps investors get a true comparison of stocks to each other within a particular sector or industry. At the same time, equal-weight ratings could change at any time.

Price Target

A price target is an analyst’s projection of a stock’s future price. A price target is generally set up in a general trade or area where the asset might land. This means that the analyst could get close without hitting the figure on the head. Even so, the analyst wants to get close and better predict the movement of the marketplace and the asset.

Understanding Stock Ratings

Stock ratings are assessments of the investment potential of a particular stock. They are typically created by financial analysts who evaluate a company's financial performance, competitive positioning, and market outlook to provide guidance on the stock's expected future performance.

Ratings typically range from "buy" to "sell," with variations in between, such as "hold," "accumulate," or "neutral." A "buy" rating suggests that the stock is likely to perform well in the future, and investors should consider purchasing it. Conversely, a "sell" rating indicates that the stock is expected to underperform, and investors should consider selling it.

It's important to note that ratings are not guarantees of performance and should not be relied upon solely when making investment decisions. Ratings are just one factor to consider when evaluating a stock's potential, and investors should also conduct their own research and analysis to make informed decisions.

Another thing to keep in mind is that different analysts may have different opinions on a stock, so it's a good idea to consider multiple ratings before making an investment decision.

In addition to analyst ratings, investors can also consider other factors when evaluating a stock, such as its financial statements, management team, industry trends, and overall market conditions. By combining all of these factors, investors can make informed decisions about which stocks to buy or sell.

In summary, stock ratings are an important tool for investors to consider when evaluating a stock's potential, but they should not be the only factor used in investment decision-making. It's important to conduct your own research, consider multiple ratings, and take into account other factors before making an investment decision.

Should You Use Analyst Ratings to Inform Your Own Trades?

You can definitely use analyst ratings to inform your own trades and inform your own thesis but it’s a good idea to do your own research. However, analyst ratings are just one step in what should be a much larger investment strategy. Don’t fall in love with just one analyst. Compare notes. Look into how these ratings match with activity on the market and current events. Plus, remember that an analyst rating could easily be incorrect. No one is perfect, but these ratings are a good place to start.

Visit Benzinga News for more guidance on how to research companies and make decisions about research, trading and investing.

Compare Online Stock Brokers

Claim Exclusive Offers

Interactive Brokers Review
Good Fit For:
Active and Global Traders
VIEW PROS & CONS:
Securely through Interactive Brokers’ website
Plus500 Review
Good Fit For:
Leveraged Trading
VIEW PROS & CONS:
securely through Plus500 Yield's website
public.com Review
Good Fit For:
Trading Ideas
VIEW PROS & CONS:
securely through public.com's website
Robinhood Review
Good Fit For:
Commission-Free Mobile Trading
VIEW PROS & CONS:
securely through Robinhood's website
TradeZero Review
Good Fit For:
Active Short Sellers
VIEW PROS & CONS:
securely through TradeZero [SPONSORED]'s website